pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·May 15·1 min read
save

#ASGCT26: A Zillow-like marketplace for abandoned gene therapies goes live

BOSTON — Two nonprofit organizations have devised a plan to help abandoned cell and gene therapies find a new home. On Thursday, the American Society of Gene & Cell Therapy (ASGCT) and the Orphan Therapeutics Accelerator ...

May 15, 2026·read at Endpoints ↗

ASGCT in Boston (Ryan Cross for Endpoints News) May 15, 2026 06:45 AM EDT Cell/Gene Tx A Zil­low-like mar­ket­place for aban­doned gene ther­a­pies goes live Ryan Cross Senior Science Correspondent BOSTON — Two non­prof­it or­ga­ni­za­tions have de­vised a plan to help aban­doned cell and gene ther­a­pies find a new home. On Thurs­day, the Amer­i­can So­ci­ety of … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
91 words · retrieved May 15
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Cell TherapyRare Disease

related stories

  • 58m agoTScan axes 75% of workforce, prioritizes solid tumor programBioSpace
  • Jul 29Updated: FDA adcomm votes down Capricor's DMD therapy over efficacyEndpoints
  • Jul 29Kyverna taps ElevateBio to secure commercial supply of autoimmune CAR-T therapyBioSpace
  • Jul 29Capricor and Replimune prep for FDA adcomms, Q2 earnings roll on, Sarepta’s new leader, moreBioSpace
  • Jul 29STAT+: FDA expert panel recommends against approval of Capricor’s Duchenne drugSTAT